Results 1 to 1 of 1

Thread: My first clinical trial

  1. #1
    PharmD Year 1 TomHsiung's Avatar
    Join Date
    Jan 2013
    Chengdu, Sichuan, China

    Default My first clinical trial

    To write these papers in the introduction to talk about their shortnesses.

    1.Factors influencing quality of anticoagulation control and warfarin dosage in patients after aortic valve replacement within the 3 months of follow up.

    2.Enzyme Polymorphism in Warfarin Dose Management After Pediatric Cardiac Surgery.

    3.VKORC1 -1639G/A and 1173 C/T Genetic Polymorphisms Influence Individual Differences in Warfarin Maintenance Dose.

    4.The effect of CYP2C9, VKORC1 and CYP4F2 polymorphism and of clinical factors on warfarindosage during initiation and long-term treatment after heart valve surgery.

    5.The combined effects of clinical factors and CYP2C9 and VKORC1 gene polymorphisms on initiating warfarin treatment in patients after cardiac valve surgery.

    6.Clinical significance of combined CYP2C9 and VKORC1 genotypes in Japanese patients requiring warfarin.

    7.Gene-based warfarin dosing compared with standard of care practices in an orthopedic surgerypopulation: a prospective, parallel cohort study.

    8.CYP2C9 polymorphism and warfarin sensitivity in Taiwan Chinese.
    Last edited by TomHsiung; Tue 5th December '17 at 11:18pm.
    B.S. Pharm, West China School of Pharmacy, Class of 2007, Health System Pharmacist, RPh. Hematology, Infectious Disease.

Posting Permissions

  • You may not post new threads
  • You may not post replies
  • You may not post attachments
  • You may not edit your posts